These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12537007)

  • 21. Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET.
    Baulieu JL; Ribeiro MJ; Levilion-Prunier C; Tranquart F; Chartier JR; Guilloteau D; Cottier JP; Besnard JC; Pourcelot L; Autret A
    Nucl Med Commun; 1999 Jan; 20(1):77-84. PubMed ID: 9949416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study.
    Pilowsky LS; Costa DC; Ell PJ; Murray RM; Verhoeff NP; Kerwin RW
    Psychol Med; 1993 Aug; 23(3):791-7. PubMed ID: 7901865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography.
    Almeida P; Ribeiro MJ; Bottlaender M; Loc'h C; Langer O; Strul D; Hugonnard P; Grangeat P; Mazière B; Bendriem B
    Eur J Nucl Med; 1999 Dec; 26(12):1580-8. PubMed ID: 10638410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visualization of extrastriatal dopamine D2 receptors in the human brain.
    Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL
    Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a population pharmacokinetic model to predict brain distribution and dopamine D2 receptor occupancy of raclopride in non-anesthetized rat.
    Wong YC; Ilkova T; van Wijk RC; Hartman R; de Lange ECM
    Eur J Pharm Sci; 2018 Jan; 111():514-525. PubMed ID: 29106979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
    Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
    Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBF.
    van Dyck CH; Seibyl JP; Stubbs JB; Zoghbi S; Wisniewski G; Baldwin RM; Zea-Ponce Y; Charney DS; Hoffer PB; Innis RB
    Nucl Med Biol; 1996 Jan; 23(1):9-16. PubMed ID: 9004921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Staedt J; Stoppe G; Kögler A; Riemann H; Hajak G; Munz DL; Emrich D; Rüther E
    J Neural Transm Gen Sect; 1995; 99(1-3):187-93. PubMed ID: 8579804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model.
    Skinbjerg M; Liow JS; Seneca N; Hong J; Lu S; Thorsell A; Heilig M; Pike VW; Halldin C; Sibley DR; Innis RB
    Neuroimage; 2010 May; 50(4):1402-7. PubMed ID: 20097293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feedback-controlled bolus plus infusion (FC-B/I) method for quantitative drug assessment in living brain with PET.
    Ohba H; Harada N; Nishiyama S; Kakiuchi T; Kimura Y; Tsukada H
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):85-90. PubMed ID: 22968323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.
    Ichise M; Ballinger JR; Golan H; Vines D; Luong A; Tsai S; Kung HF
    J Nucl Med; 1996 Mar; 37(3):513-20. PubMed ID: 8772658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.
    Ichise M; Ballinger JR; Tanaka F; Moscovitch M; St George-Hyslop PH; Raphael D; Freedman M
    J Nucl Med; 1998 Sep; 39(9):1511-8. PubMed ID: 9744333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
    Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
    J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.
    al-Tikriti MS; Baldwin RM; Zea-Ponce Y; Sybirska E; Zoghbi SS; Laruelle M; Malison RT; Kung HF; Kessler RM; Charney DS
    Nucl Med Biol; 1994 Feb; 21(2):179-88. PubMed ID: 9234281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.
    Ikoma Y; Ito H; Arakawa R; Okumura M; Seki C; Shidahara M; Takahashi H; Kimura Y; Kanno I; Suhara T
    Neuroimage; 2008 Oct; 42(4):1285-94. PubMed ID: 18585466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.